Close
ACHEMA MIDDLE EAST 2026

Singapore Creates Ingestible Capsule For Radiation Track

A novel discovery by the researchers at the National University of Singapore can go on to aid in the treatment of gastric cancer by...

New Research Projects For Growth From The Office of The FDA

In 2018, the FDA’s Centre for Drug Evaluation and Research’s Office of New Drugs- OND went on to develop a new programme so as...

Singapore – Sweden Research Offers Stem Cell Vision Recovery

Preclinical study making use of stem cells to develop progenitor photoreceptor cells-light detecting cells found in the eye and thereafter transplanting these cells into...

Brain Tumour In Mice Gets A Hope of Traditional Chinese Drug

A new study demonstrates how a medication derived from a natural component used in classical Chinese medicine works over malignant brain tumours in mice,...

Australia Scientists Replicate Human Lungs To Test Drugs

University of Australia scientists, with collaborators from South Korea, China, and, of course, Australia, have gone on to develop a step-wise blueprint so as...

New Targeted Cancer Treatment Therapies Scouted By Singapore

Cancer happens to be a leading cause of global death and accounts for almost one in six fatalities, with metastatic cancers contributing more than...

Ghana Gives Go Ahead To Oxford University Malaria Vaccine

A malaria vaccine called R21/Matrix-M, which was developed in collaboration with the University of Oxford as well as a manufacturer of vaccines and immunological...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...